Trial intelligence / Profile preview

Cytokines and Growth in Children With CRI and ESRD

NCT00194883Phase 4Suspended

Sponsor
Weill Cornell Medicine
Start
Apr 1997
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of somatropin in Growth failure (FTT), sponsored by Weill Cornell Medicine. Started Apr 1997; status: suspended.

02

Drugs

somatropin
03

Conditions

Growth failure (FTT)

Beyond the preview

Go deeper on NCT00194883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00194883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call